Lab-Grown skin patch could mend wounds for rare blistering disease patients
NCT ID NCT07193134
First seen Nov 01, 2025 · Last updated May 18, 2026 · Updated 32 times
Summary
This early-stage trial tests a new skin graft made from a patient's own cells, genetically modified to produce a missing protein that helps skin stay attached. The graft is designed to be permanent and aims to heal wounds in people with recessive dystrophic epidermolysis bullosa (RDEB), a severe genetic blistering condition. Up to 9 participants aged 7 and older will be monitored for safety and wound healing over 12 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RDEB are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Hospital for Sick Children (SickKids)
RECRUITINGToronto, Ontario, M5G 1E8, Canada
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.